{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:33:33Z","timestamp":1762004013294,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":5611,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1038\/modpathol.3800826","type":"journal-article","created":{"date-parts":[[2007,7,20]],"date-time":"2007-07-20T12:45:30Z","timestamp":1184935530000},"page":"929-935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders"],"prefix":"10.1016","volume":"20","author":[{"given":"Pin-Pen","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy J","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis P","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergej N","family":"Konoplev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry W","family":"Hussong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cherie H","family":"Dunphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherrie L","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Che","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.3800826_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajh.2830110307","article-title":"Hematopoiesis in the human spleen","volume":"11","author":"Freedman","year":"1981","journal-title":"Am J Hematol"},{"key":"10.1038\/modpathol.3800826_bib2","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/1097-0142(19890415)63:8<1539::AID-CNCR2820630814>3.0.CO;2-5","article-title":"The pathogenesis of splenic extramedullary hematopoiesis in metastatic carcinoma","volume":"63","author":"O'Keane","year":"1989","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3800826_bib3","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/modpathol.3800480","article-title":"Morphologic and immunohistochemical evaluation of splenic hematopoietic proliferations in neoplastic and benign disorders","volume":"18","author":"O'Malley","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.3800826_bib4","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/modpathol.3800481","article-title":"Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemia","volume":"18","author":"O'Malley","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.3800826_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2559.1994.tb00516.x","article-title":"Extramedullary haemopoiesis in fetal and adult human spleen: a quantitative immunohistological study","volume":"24","author":"Wilkins","year":"1994","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.3800826_bib6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1038\/modpathol.3800826_bib7","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1038\/modpathol.3800826_bib8","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800826_bib9","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.3800826_bib10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1365-2141.2006.06483.x","article-title":"JAK2 (V617F) mutation in healthy individuals","volume":"136","author":"Passamonti","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.3800826_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2141.2005.05764.x","article-title":"JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance","volume":"131","author":"Wolanskyj","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.3800826_bib12","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2005-05-1898","article-title":"The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia","volume":"106","author":"Levine","year":"2005","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800826_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.seminhematol.2005.05.019","article-title":"Role of tyrosine kinases and phosphatases in polycythemia vera","volume":"42","author":"Zhao","year":"2005","journal-title":"Semin Hematol"},{"key":"10.1038\/modpathol.3800826_bib14","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood-2005-10-009514","article-title":"Constitutive activation of STAT5 and Bcl-xL overexpression can induce endogenous erythroid colony formation in human primary cells","volume":"108","author":"Garcon","year":"2006","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800826_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(03)00411-3","article-title":"Of JAKs STATs, blind watchmakers, jeeps and trains","volume":"546","author":"Kerr","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1038\/modpathol.3800826_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(00)81013-2","article-title":"Fetal anemia and apoptosis of red cell progenitors in Stat5a\u2212\/\u22125b\u2212\/\u2212 mice: a direct role for Stat5 in Bcl-X(L) induction","volume":"98","author":"Socolovsky","year":"1999","journal-title":"Cell"},{"key":"10.1038\/modpathol.3800826_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.nbd.2006.08.007","article-title":"Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia","volume":"25","author":"Zhang","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1038\/modpathol.3800826_bib18","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800826_bib19","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1182\/blood.V97.11.3665","article-title":"Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia","volume":"97","author":"Mesa","year":"2001","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800826_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cncr.20343","article-title":"Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder","volume":"101","author":"Cheng","year":"2004","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3800826_bib21","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/cncr.11747","article-title":"Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma","volume":"98","author":"Paterson","year":"2003","journal-title":"Cancer"},{"key":"10.1038\/modpathol.3800826_bib22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.5858\/2006-130-997-DOTJMI","article-title":"Detection of the JAK2(V617F) mutation in myeloproliferative disorders by melting curve analysis using the LightCycler system","volume":"130","author":"Olsen","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/modpathol.3800826_bib23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/hed.20267","article-title":"C-erb-B2 (HER2\/neu) expression in synovial sarcoma of the head and neck","volume":"27","author":"Olsen","year":"2005","journal-title":"Head Neck"},{"key":"10.1038\/modpathol.3800826_bib24","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ajo.2005.05.038","article-title":"BCL10 expression in ocular adnexal lymphomas","volume":"140","author":"Vejabhuti","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1038\/modpathol.3800826_bib25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1309\/JT5BE2L1FGG8P8Y6","article-title":"Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia","volume":"126","author":"Lin","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.3800826_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2353\/jmoldx.2006.060007","article-title":"JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology","volume":"8","author":"Steensma","year":"2006","journal-title":"J Mol Diagn"},{"key":"10.1038\/modpathol.3800826_bib27","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","article-title":"The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u2018atypical' myeloproliferative disorders and myelodysplastic syndromes","volume":"106","author":"Steensma","year":"2005","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1038\/modpathol.3800826_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/10245330512331390456","article-title":"Clinical, pathological and molecular features of the chronic myeloproliferative disorders: MPD 2005 and beyond","volume":"10","author":"Michiels","year":"2005","journal-title":"Hematology"},{"key":"10.1038\/modpathol.3800826_bib29","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1038\/sj.leu.2403989","article-title":"The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients","volume":"19","author":"Ohyashiki","year":"2005","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.3800826_bib30","first-page":"355","article-title":"Hematopathologic findings in the myeloproliferative disorders","volume":"22","author":"Dickstein","year":"1995","journal-title":"Semin Oncol"},{"key":"10.1038\/modpathol.3800826_bib31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.leu.2404060","article-title":"Mutational screen reveals a novel JAK2 mutation, L611S, in a child with acute lymphoblastic leukemia","volume":"20","author":"Kratz","year":"2006","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.3800826_bib32","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2141.2005.05682.x","article-title":"Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2(V617F) in granulocytes","volume":"130","author":"Lasho","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.3800826_bib33","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/sj.onc.1209163","article-title":"The JAK2 V617F mutation in de novo acute myelogenous leukemias","volume":"25","author":"Lee","year":"2005","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.3800826_bib34","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood-2006-04-014712","article-title":"JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model","volume":"108","author":"Mercher","year":"2006","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800826_bib35","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","article-title":"MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients","volume":"108","author":"Pardanani","year":"2006","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800826_bib36","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med"},{"key":"10.1038\/modpathol.3800826_bib37","first-page":"1061","article-title":"Correlations of JAK2-V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders","volume":"31","author":"Speletas","year":"2006","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.3800826_bib38","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood-2005-12-013748","article-title":"Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation","volume":"108","author":"Campbell","year":"2006","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800826_bib39","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1182\/blood-2005-08-3395","article-title":"V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis","volume":"107","author":"Campbell","year":"2006","journal-title":"Blood"},{"key":"10.1038\/modpathol.3800826_bib40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2141.2005.05858.x","article-title":"The presence of the JAK2 V617F mutation is associated with a higher haemoglobin and increased risk of thrombosis in essential thrombocythaemia","volume":"132","author":"Cheung","year":"2006","journal-title":"Br J Haematol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3800826.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3800826","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222032665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222032665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3800826.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:08:26Z","timestamp":1760231306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222032665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0893395222032665"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.3800826","relation":{},"ISSN":["0893-3952"],"issn-type":[{"type":"print","value":"0893-3952"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.3800826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}